P1653: CLINICAL EFFICACY AND SAFETY OF SWITCHING ELTROMBOPAG AND RH-TPO IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA DURING THE COVID-19 PANDEMIC

• X. Cai,
• X.-H. Zhang

Affiliations

X. Cai

1 Peking University Institute of Hematology, Peking University People’s Hospital, Beijing, China

X.-H. Zhang

1 Peking University Institute of Hematology, Peking University People’s Hospital, Beijing, China